Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans [PDF]
K A Laxalt, Thomas R. Kozel
openalex +1 more source
Complement activation in patients with COVID-19: A novel therapeutic target
M. Cugno+10 more
semanticscholar +1 more source
Complement activation in human prion disease
The central event in the neuropathological process of prion diseases (PrD) is the accumulation of abnormal prion protein accompanied by severe neuronal loss.
Gabor G Kovacs+7 more
doaj
Inactivation or elimination of potentially trypanolytic, complement-activating immune complexes by pathogenic trypanosomes [PDF]
Andrew E. Balber+3 more
openalex +1 more source
Alternative Pathway of Complement Activation in Full Term and Premature Infants [PDF]
Robert C. Strunk+2 more
openalex +1 more source
Self-organised dynamics and emergent shape spaces of active isotropic fluid surfaces [PDF]
Theories of self-organised active fluid surfaces have emerged as an important class of minimal models for the shape dynamics of biological membranes, cells and tissues. Here, we develop and apply a variational approach for active fluid surfaces to systematically study the nonlinear dynamics and emergent shape spaces such theories give rise to.
arxiv
Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway. [PDF]
J W Tauber+2 more
openalex +1 more source
Statistics of Extremes for Neuroscience [PDF]
This chapter illustrates how tools from univariate and multivariate statistics of extremes can complement classical methods used to study brain signals and enhance the understanding of brain activity and connectivity during specific cognitive tasks or abnormal episodes, such as an epileptic seizure.
arxiv
Peptide redesign for inhibition of the complement system: Targeting age-related macular degeneration. [PDF]
PurposeTo redesign a complement-inhibiting peptide with the potential to become a therapeutic for dry and wet age-related macular degeneration (AMD).MethodsWe present a new potent peptide (Peptide 2) of the compstatin family.
Cabrera, Andrea P+6 more
core +1 more source
C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM. [PDF]
M M Hurst+3 more
openalex +1 more source